The European Medicines Agency (EMA) has similar reduced racemic drug approvals and has shown an increasing trend towards single‐enantiomer drugs.
← all excerpts
Chiral (Stereoselective) Drugs, Asymmetric Synthesis, and Racemic Resolution Methods.
1
—
—